Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways
Ioannis K. Zervantonakis(University of Pittsburgh), Joan S. Brugge(Harvard University), Matthew D. Poskus(UPMC Hillman Cancer Center), Laura M. Selfors(Harvard University), Jia‐Ren Lin(Harvard University), Peter K. Sorger(Harvard University Press), Deborah Dillon(Harvard University), Shailja Pathania(Harvard University), Alexis L. Scott(University of Pittsburgh), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 33
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k